Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography–Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
- 1 December 2018
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 196, 154-164
Abstract
No abstract availableKeywords
Funding Information
- National Eye Institute (EY022039, EY027945, EY11008, P30EY022589, EY026590, EY027510, EY026574, EY023704, EY026574, EY018926)
- Eyesight Foundation of Alabama (Birmingham, Alabama, USA)
- Alcon Laboratories Inc (Fort Worth, Texas, USA)
- Allergan Inc (Irvine, California, USA)
- Pfizer Inc (New York, New York, USA)
- Merck Inc (Kenilworth, New Jersey, USA)
- Santen Inc (Tokyo, Japan)
This publication has 36 references indexed in Scilit:
- Signal-to-Noise Ratios for Structural and Functional Tests in GlaucomaTranslational Vision Science & Technology, 2013
- Optic Disc Margin Anatomy in Patients with Glaucoma and Normal Controls with Spectral Domain Optical Coherence TomographyOphthalmology, 2012
- Variation in Optic Nerve and Macular Structure with Age and Race with Spectral-Domain Optical Coherence TomographyOphthalmology, 2011
- African Descent and Glaucoma Evaluation Study (ADAGES)Archives of Ophthalmology (1950), 2010
- African Descent and Glaucoma Evaluation Study (ADAGES)Archives of Ophthalmology (1950), 2010
- Retinal Thickness Analysis by Race, Gender, and Age Using Stratus OCTAmerican Journal of Ophthalmology, 2010
- The African Descent and Glaucoma Evaluation Study (ADAGES)Archives of Ophthalmology (1950), 2009
- Variations in Primary Open-Angle Glaucoma Prevalence by Age, Gender, and Race: A Bayesian Meta-AnalysisInvestigative Ophthalmology & Visual Science, 2006
- The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucomaAmerican Journal of Ophthalmology, 2002
- Glaucoma in blacks: where do we go from here?1989